» Articles » PMID: 32843543

A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium Parvum

Overview
Journal mBio
Specialty Microbiology
Date 2020 Aug 27
PMID 32843543
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

spp., protozoan parasites, are a leading cause of global diarrhea-associated morbidity and mortality in young children and immunocompromised individuals. The limited efficacy of the only available drug and lack of vaccines make it challenging to treat and prevent cryptosporidiosis. Therefore, the identification of essential genes and understanding their biological functions are critical for the development of new therapies. Currently, there is no genetic tool available to investigate the function of essential genes in spp. Here, we describe the development of the first conditional system in Our system utilizes the dihydrofolate reductase degradation domain (DDD) and the stabilizing compound trimethoprim (TMP) for conditional regulation of protein levels in the parasite. We tested our system on the calcium-dependent protein kinase-1 (CDPK1), a leading drug target in By direct knockout strategy, we establish that is refractory to gene deletion, indicating its essentiality for parasite survival. Using CRISPR/Cas9, we generated transgenic parasites expressing CDPK1 with an epitope tag, and localization studies indicate its expression during asexual parasite proliferation. We then genetically engineered to express CDPK1 tagged with DDD. We demonstrate that TMP can regulate CDPK1 levels in this stable transgenic parasite line, thus revealing the critical role of this kinase in parasite proliferation. Further, these transgenic parasites show TMP-mediated regulation of CDPK1 levels and an increased sensitivity to kinase inhibitor upon conditional knockdown. Overall, this study reports the development of a powerful conditional system that can be used to study essential genes in and are leading pathogens responsible for diarrheal disease (cryptosporidiosis) and deaths in infants and children below 5 years of age. There are no effective treatment options and no vaccine for cryptosporidiosis. Therefore, there is an urgent need to identify essential gene targets and uncover their biological function to accelerate the development of new and effective anticryptosporidial drugs. Current genetic tool allows targeted disruption of gene function but leads to parasite lethality if the gene is essential for survival. In this study, we have developed a genetic tool for conditional degradation of proteins in spp., thus allowing us to study the function of essential genes. Our conditional system expands the molecular toolbox for , and it will help us to understand the biology of this important human diarrheal pathogen for the development of new drugs and vaccines.

Citing Articles

Involvement of INS15 in the development and pathogenicity of the zoonotic pathogen Cryptosporidium parvum.

He W, Cui H, Li N, Guo Y, Zeng S, Feng Y PLoS Negl Trop Dis. 2024; 18(10):e0012569.

PMID: 39361715 PMC: 11478815. DOI: 10.1371/journal.pntd.0012569.


Optimization of a DiCre recombinase system with reduced leakage for conditional genome editing of Cryptosporidium.

Huang Y, Li J, Pei S, You H, Liu H, Guo Y Parasit Vectors. 2024; 17(1):352.

PMID: 39169430 PMC: 11337648. DOI: 10.1186/s13071-024-06431-1.


γ-tubulin complex controls the nucleation of tubulin-based structures in Apicomplexa.

Haase R, Puthenpurackal A, Maco B, Guerin A, Soldati-Favre D Mol Biol Cell. 2024; 35(9):ar121.

PMID: 39046777 PMC: 11449391. DOI: 10.1091/mbc.E24-03-0100.


Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium.

Waldron-Young E, Wijitrmektong W, Choi R, Whitman G, Hulverson M, Charania R Mol Biochem Parasitol. 2024; 260:111637.

PMID: 38901801 PMC: 11629397. DOI: 10.1016/j.molbiopara.2024.111637.


The Cryptosporidium signaling kinase CDPK5 plays an important role in male gametogenesis and parasite virulence.

Nava M, Szewczyk J, Arrington J, Alam T, Vinayak S Cell Rep. 2024; 43(6):114263.

PMID: 38814783 PMC: 11312397. DOI: 10.1016/j.celrep.2024.114263.


References
1.
Baragana B, Forte B, Choi R, Hewitt S, Bueren-Calabuig J, Pisco J . Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Proc Natl Acad Sci U S A. 2019; 116(14):7015-7020. PMC: 6452685. DOI: 10.1073/pnas.1814685116. View

2.
Perryman L, Jasmer D, Riggs M, Bohnet S, McGuire T, Arrowood M . A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol Biochem Parasitol. 1996; 80(2):137-47. DOI: 10.1016/0166-6851(96)02681-3. View

3.
Pino P, Sebastian S, Kim E, Bush E, Brochet M, Volkmann K . A tetracycline-repressible transactivator system to study essential genes in malaria parasites. Cell Host Microbe. 2012; 12(6):824-34. PMC: 3712325. DOI: 10.1016/j.chom.2012.10.016. View

4.
Ma Y, Weiss L, Huang H . A method for rapid regulation of protein expression in Trypanosoma cruzi. Int J Parasitol. 2011; 42(1):33-7. PMC: 3249466. DOI: 10.1016/j.ijpara.2011.11.002. View

5.
Lendner M, Bottcher D, Delling C, Ojo K, Van Voorhis W, Daugschies A . A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?. Parasitol Res. 2014; 114(1):335-6. PMC: 7087976. DOI: 10.1007/s00436-014-4228-7. View